SCHEMBL8172276

SCHEMBL8172276

CC(=O)OC(=O)CCC1CCN(CCC=C2c3ccccc3Sc3ccccc32)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.60
USP2 O75604 4/20 0.46
CYP2D6 P10635 4/20 0.46
CYP3A4 P08684 3/20 0.46
CYP1A2 P05177 3/20 0.46
CYP2C19 P33261 2/20 0.46
TP53 P04637 2/20 0.46
TSHR P16473 2/20 0.46
NFKB1 P19838 2/20 0.46
KCNK2 O95069 1/20 0.46
MAPK1 P28482 1/20 0.46
THPO P40225 1/20 0.46
HTR1A P08908 4/20 0.46
DRD2 P14416 4/20 0.46
ADRA2B P18089 4/20 0.46
ADRA1A P35348 4/20 0.46
HRH1 P35367 4/20 0.46
LMNA P02545 3/20 0.46
ADRA2C P18825 3/20 0.46
HTR2A P28223 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8181729 0.88 SIGMAR1 (0.60) SIGMAR1USP2CYP2D6CYP3A4CYP1A2
Acetic Acid SCHEMBL8172274 0.87 SIGMAR1 (0.64) SIGMAR1USP2CYP2D6CYP3A4CYP1A2
SCHEMBL7603081 0.86 SIGMAR1 (0.64) SIGMAR1USP2CYP2D6CYP3A4CYP1A2
SCHEMBL7605940 0.81 SIGMAR1 (0.60) SIGMAR1USP2CYP2D6CYP3A4CYP1A2
SCHEMBL19127667 0.77 SIGMAR1 (0.70) SIGMAR1USP2CYP2D6CYP3A4CYP1A2
SCHEMBL19153976 0.76 SIGMAR1 (0.65) SIGMAR1USP2CYP2D6CYP3A4CYP1A2
SCHEMBL8187171 0.75 SIGMAR1 (0.43) SIGMAR1HTR1ADRD2ADRA2BADRA1A
SCHEMBL8173072 0.74 SIGMAR1 (0.42) SIGMAR1TSHRHTR1ADRD2ADRA2B
SCHEMBL7609508 0.74 SIGMAR1 (0.49) SIGMAR1USP2CYP2D6CYP3A4CYP1A2
SCHEMBL20678554 0.73 SIGMAR1 (0.65) SIGMAR1USP2CYP2D6CYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6114354-A N-substituted azaheterocyclic compounds NOVO NORDISK A/S (DK) 2000-09-05 US disclosed
US-6100253-A 3-(1-(3-(XANTHEN-9-YLIDENE)-1-PROPYL)PIPERIDIN-4-YL)PROPIONIC ACID, FOR EXAMPLE; TREATING NON-INSULIN DEPENDENT DIABETES, NEUROGENIC INFLAMMATION AND OBESITY; INTERFERE WITH C-FIBERS TO INHIBIT SECRETION OF INSULIN ANTAGONISING PEPTIDES NOVO NORDISK A/S (DK) 2000-08-08 US disclosed
US-6066632-A ANALGESICS; ANTIINFLAMMATORY AGENTS NOVO NORDISK A/S (DK) 2000-05-23 US disclosed
EP-0991621-A1 NOVEL HETEROCYCLIC COMPOUNDS NOVO NORDISK A/S (DK) 2000-04-12 EP disclosed
US-6040318-A TREATING INSULIN RESISTANT NON-INSULIN-DEPENDENT DIABETES MELLITUS AND AGEING-ASSOCIATED OBESITY, NEUROGENIC INFLAMMATION ASSOCIATED WITH NEUROPATHY OR RHEUMATOID ARTHRITIS NOVO NORDISK A/S (DK) 2000-03-21 US disclosed
WO-1999000367-A1 NOVEL HETEROCYCLIC COMPOUNDS NOVO NORDISK A/S (DK) 1999-01-07 WO disclosed